Joint Symposium: Implementation of HIV pre-exposure prophylaxis (PrEP) in Australia and New Zealand
Tracks
2
| Wednesday, November 8, 2017 |
| 2:15 PM - 3:45 PM |
| Royal Theatre |
Details
With the science of HIV pre-exposure prophylaxis (PrEP) effectiveness largely determined, attention now focuses on optimising the effectiveness of implementation strategies. This session will focus on issues related to the effective implementation of PrEP in Australia and New Zealand. The session will draw upon the evolution of PrEP availability and scale-up, policy and practice, current thinking in relation to clinical guidelines and priority populations and insights on future issues arising in Australia from the potential PBS listing of Truvada as PrEP. The following learning objectives will be provided: • Increased awareness of PrEP implementation issues
• Understanding of the intersection between features of PrEP implementation and HIV prevention effectiveness
• Greater knowledge of opportunities and challenges to PrEP implementation in Australia and New Zealand
Speaker
Attendee640
Attendee1375
Attendee327
Attendee945
Attendee674
Attendee1174
Discussion
3:30 PM - 3:45 PMBiography
